8Jhala D, Eltoum I. Barrier to adoption of recent technology in cervi- cal cancer in rural India. 1~I Engl J Med, 2009, 360 (14): 1385-1394.
9Clavel C, Cucherousset J, Lorenzato M, et al. Negative hunan pap- illomaviurs testing in normal semears selects a population at low riskfor developing high-grade cervical leions. Br J Cancer, 2004, 90 (9) :1803-1808.
10Sandri MT,lentafi P, Benini E, et al. Comparison of Digene HC2 aay and the Roche. AMPLIOCOR human papilloma-virus ( HPV )test for detection of high-risk HPV genotypes in cervical ample. J Clin Microbio1,2006 ,44 (6) :2141-2146.